NHNajah Rayish Hadi

Najah Rayish Hadi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Najah Rayish Hadi has a total of 204 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Can hydrogen-rich water increase nitrite and nitric oxide in patients with central obesity?

    by Ram B. Singh, Monika Jankajova, Divyank Sharma, Sarthak Sharma, Mohammad Arif Niaz, Oleg Medvedev, Peter Stefanic, Alexander Tarnava, Duried Alwazeer, Emel Uçarer, et al.

    Background: Inflammation and oxidative stress play important roles in the pathophysiology of cardiovascular diseases. Hydrogen therapy, due to its antioxidant activity, has become a supplementary treatment. Objective: This study aims to investigate whether hydrogen-rich water (HRW) affects nitrite levels, a precursor of nitric oxide. Methods: Of 71 patients who volunteered, only 60 were selected due to the presence of metabolic syndrome and were randomly divided into either an intervention (HRW; n = 30) or placebo group (n = 30) using a computer-generated random number sequence, with participants blinded to the intervention. The participants consumed one tablet three times daily with 250–500 mL of water, and drank the entire solution immediately after complete dissolution on an empty stomach. Results: A significant increase in nitrite levels (8.2% vs. −1.5%, p < 0.001) was observed in the HRW group compared with the control group at the end of the 24-week follow-up, , with a modest decrease in the control group (0.66 ± 0.15 vs. 0.64 ± 0.14, p > 0.05). Thiobarbituric acid-reactive substances, malondialdehyde, and diene conjugate levels, as well as cytokine levels (tumor necrosis factor α and interleukin-6), did not differ significantly at baseline. However, after 12 and 24 weeks, all these biomarkers showed a significant decline in the HRW group, but not in the control group. Conclusion: Treatment with HRW may cause a possible increase in nitrite levels and decrease markers of inflammation and oxidative stress. It is likely that another possible mechanism of benefit from hydrogen therapy may be through an increase in nitrite levels. Relevance for patients: Hydrogen therapy may help protect against cardiovascular diseases.

  • Open Access

    Vericiguat: The Fifth Pillar of Heart Failure

    by Ram B Singh, Najah R Hadi, Abdulla Shehab, Galal Elkilany

  • Ameliorative effects of bevacizumab against sepsis-induced acute kidney injury: investigation of inflammatory responses, pyroptosis-related signalling and angiogenesis in a murine model of polymicrobial sepsis

    by Heider Qassam, Karrar Kareem Gaen, Ammar Azzam, Ahmed Mh Al-Mudhafar, Rihab Hameed Almudhafar, Najah R. Hadi

    Sepsis is a clinical issue with a major impact on in-hospital patients, resulting in multiple organ damage and increased risk of death. Acute kidney injury (AKI) is the most common organ that is vulnerable to sepsis and may progress to renal failure if not treated. Bevacizumab is a biopharmaceutical agent that disrupts the angiogenesis signalling pathway by binding to vascular endothelial growth factor (VEGF) and preventing it from coupling with cognate receptors. The present study aimed to assess the renoprotective potential of bevacizumab against sepsis-induced renal injury. Four cohorts (6 mice per group) were randomly allocated and included a sham cohort, which was exposed to a midline incision only; the cecal ligation and puncture (CLP) cohort underwent CLP; the vehicle cohort was pretreated with normal saline 1 h prior to the CLP; and the bevacizumab cohort was treated with 0.1 mg/kg bevacizumab 1 h before the CLP. After 24 h, the mice were euthanised, and the blood and kidneys were collected. The results revealed that the levels of urea, creatinine, TNF-α, IL-6, caspase 11, ICAM-1, VEGF and angiopoietin-2 were greater in septic mice than in sham mice. These levels were decreased in septic mice pretreated with bevacizumab. Histological assessment of renal tissues revealed that the kidneys of septic mice were injured, influencing 90% of the renal tubules. Pretreatment with bevacizumab mitigated renal tissue damage. This study demonstrated that bevacizumab has promising renoprotective effects against sepsis-induced renal injury via modulation of inflammatory responses, angiogenesis and pyroptosis-associated signalling.

  • Open Access

    Toward Personalized Treatment: Circadian Gene Expression and Precision Medicine in Fibromyalgia

    by Sadaf Khan, Ghizal Fatima, Abbas Ali Mahdi, Ammar Mehdi Raza, Yulia Sh. Gushchina, Hemali Jha, Najah Hadi

    Fibromyalgia (FM) is a multifactorial chronic pain disorder characterized by widespread pain, sleep disturbance, fatigue, cognitive dysfunction, and neuroendocrine-immune imbalance. Growing evidence indicates that circadian dysregulation plays a role in FM pathophysiology, although current evidence is largely associative and mechanistic. Altered molecular clock function—including disruptions in the PER-CRY-CLOCK-BMAL1 transcriptional feedback loop—affects sleep–wake timing, hormone secretion, neurotransmission, and immune activity, all of which are systems consistently impaired in FM. Clinical studies reveal blunted or phase-shifted melatonin and cortisol rhythms, dampened rest-activity cycles, and an overrepresentation of evening chronotypes, which are associated with higher pain severity and poorer sleep. Genetic and epigenetic findings further implicate circadian biology: PER3 VNTR polymorphisms increase FM susceptibility, while differential DNA methylation patterns, microRNA dysregulation, and transcriptomic signatures highlight abnormalities in inflammatory, glutamatergic, adrenergic, and immune pathways that are themselves under circadian control. These mechanistic disturbances have direct therapeutic relevance. Core FM medications—including analgesics, antidepressants, anticonvulsants, and sleep aids—exhibit circadian variation in pharmacokinetics and pharmacodynamics, suggesting that dosing time may influence efficacy, toxicity, and symptom relief. Emerging evidence supports chronotherapeutic strategies such as morning bright-light therapy, nighttime melatonin, structured sleep–wake scheduling, and time-aligned medication administration to reinforce circadian alignment and improve pain, fatigue, sleep quality, and mood. While clinical trials suggest symptomatic improvement with melatonin supplementation, effect sizes vary, and long-term randomized evidence remains limited. This review integrates current molecular, genetic, and clinical evidence linking circadian biology to FM and outlines how chronopharmacology and chronotherapy could advance precision medicine in this population. Future integration of multi-omics profiling, wearable-based digital phenotyping, and personalized circadian biomarkers may enable mechanism-guided, rhythm-informed management of FM.

  • Unraveling the Tapestry of Health: The Intricate Dance of Circadian Rhythms and Human Diseases

    by Sidrah Parvez, Andrej Dzupina, Ghizal Fatima, Najah Hadi, Jan Fedacko, Aminat Magomedova, Ammar Mehdi Raza, Nasser Ghaly Yousif, Hekmat B. Alhmadi

  • Open Access

    Role of chrononutrition in modulating metabolic and cardiovascular health

    by Vani Shukla, Sahil Hussain, Ghizal Fatima, Sadaf Khan, Najah Hadi, Jan Fedacko, Aminat Magomedova

    Maintaining optimal cardiovascular and metabolic health depends on aligning dietary practices with the body's intrinsic circadian rhythms. Chrononutrition is a rapidly advancing research area that explores how the timing of food intake influences physiological health outcomes. Unlike conventional nutritional strategies that emphasise food quantity and composition, chrononutrition highlights meal timing as a critical regulator of metabolic processes, including glucose metabolism, insulin responsiveness and lipid regulation. Accumulating evidence indicates that unfavourable eating behaviours, particularly late-day or nighttime food consumption, are closely associated with metabolic impairments and an increased risk of conditions such as obesity, type 2 diabetes and cardiovascular disease. By integrating principles of nutrition with chronobiology, chrononutrition offers a promising approach for reducing the burden of chronic diseases. This review evaluates the role of chrononutrition in metabolic and cardiovascular health, with particular emphasis on time-restricted eating (TRF), consistency in meal timing and the underlying molecular mechanisms responsible for the observed health benefits. Overall, the findings suggest that dietary strategies synchronised with biological clocks may represent an effective approach for chronic disease prevention.

  • Effect of topically applied simvastatin plus Luteolin on enhancing the development of hair in male mice

    by Sarmad Nory Gany, Ahmed Al-Mudhafar, Heider Qassam, Marwa Ali Kadhum, Najah Rayish Hadi

    Aim: Aim: The aim of this study to examine the effect of simvastatin and Luteolin in regrowing hair and stop hair loss in male mice.Material and methods: Materials and Methods: 25 adult male mice, weighing 25–35 g and aging 6-7 weeks, were employed. Male mice had their coat hairs on their dorsal skin, which was then carefully trimmed by an electrical machine and colored with a dye. Mice were divided into five equal groups (5 mice in each group) as follows: sham group (ethanol-treated group); Minoxidil-treated group; simvastatin-treated group; Luteolin-treated group; simvastatin and Luteolin coadministration group. The drugs were applied on the skin once daily for three weeks.Results: Results: We demonstrated that the tissue levels of total antioxidant capacity (TAC), vascular endothelia growth factor (VEGF) and keratinocyte growth factor (KGF) in the Minoxidil-treated group, simvastatin-treated group, Luteolin-treated group, and simvastatin and Luteolin coadministration group were considerably greater than those of the sham (ethanol) groups. Furthermore, these groups revealed significant increases in hair growth, hair count, and hair follicle diameters.Conclusions: Conclusion: these results have identified that simvastatin and Luteolin significantly reduced hair loss due to their anti-inflammatory and antioxidant capabilities.

  • Open Access

    Dimethyl fumarate attenuates liver injury in a mouse model of cecal ligation and puncture by modulating inflammatory, angiogenic and pyroptotic pathways

    by Heider Qassam, Ali M. Janabi, Karrar Kareem Gaen, Najah Rayish Hadi

    Sepsis is a prevalent ailment that significantly affects hospitalized individuals around the globe. It is characterized by uncontrolled inflammatory responses resulting in organ injury and leading to high morbidity and mortality. The liver, a vital organ, is affected by sepsis, resulting in liver dysfunction. Dimethyl fumarate (DMF), which is approved for the treatment of multiple sclerosis, has anti-inflammatory and neuroprotective properties through the inhibition of multiple inflammatory mediators. Hence, the present study aimed to assess the hepatoprotective potential of DMF against sepsis. Four groups of mice (6 animals per group) were divided into a sham group, which was subjected to only anaesthesia and a midline abdominal incision; the cecal ligation and puncture (CLP) group was anaesthetized and underwent an abdominal incision followed by the ligation of the cecum under the ileocecal valve and perforation twice with a needle; the vehicle group was given a solvent of DMF 1 h before the CLP, and the CLP group received 50 mg/kg of DMF via intraperitoneal (ip) injection 1 h before CLP. Following the procedure (24 h post-CLP), the mice were given unrestricted access to food and drink throughout the day. Serum was used to measure the levels of angiopoietin 2, AST and ALT. Enzyme-linked immunosorbent assay (ELISA) was used to investigate the levels of TNF-α, IL-6, MIF, ICAM-1, F2-isoprostanes, VEGF, and caspase 11 in liver tissues. To evaluate the degree of liver damage, a biopsy of the liver was performed. The results revealed that mice exposed to CLP had high levels of AST and ALT in comparison with sham mice. Furthermore, levels of TNF-α, IL-6, MIF, ICAM-1, F2-isoprostanes, VEGF, and caspase 11 in liver tissues were also notably elevated as compared with sham mice. The levels of these parameters were significantly decreased in septic mice pre-treated with DMF. Mice with CLP showed a severe degree of liver damage as compared with sham mice. DMF pre-treatment mitigated liver injury. This study suggests that DMF has hepatoprotective effects on septic mice via the modulation of inflammation, adhesion molecules, angiopoietin 2 and pyroptosis.


  • Association of Program Cell Death Ligand-1 (rs4143815 G>C) with some Clinical Symptoms and Oral Ulcer Types in Systemic Lupus Erythematosus

    by Mona Al-Terehi, Mohammed Faris Jabaz, Ola Hatif Hazim, Najah Rayish Hadi

    Aim: Amis: The study aims to detect Association of Program Cell Death Ligand-1(PD-L1) rs4143815 G>C with some Clinical Symptoms and Oral Ulcer Types in Systemic Lupus Erythematosus (SLE).Material and methods: Methodology: a case control design was suggested in the study enrolled about 60 SLE patients and 20 healthy individuals as a control group, PD-L1 variation implemented using allele specific PCR.Results: Result: the findings showed significant changes in age (pC) genotyping distribution according to some clinical symptoms showed a non-significant association with all symptoms. The PD-L1 rs4143815 (G>C) genotyping distribution according to oral ulcer sites showed a non-significant association also.Conclusions: Conclusion: the present results concluded closed correlation between rs4143815 G>C and SLE patients, but no association was observed with some clinical symptoms and oral ulcer types.


  • Open Access

    Potential Cardioprotective effect of Trimetazidine in Mice model of endotoxemia: role of AMPK-Nrf2

    by Alaa Kadhum Mosa, Sahar Majeed, Fadhaa Abdulameer Ghafil, Najah Rayish Hadi

    Aim: Background: Polymicrobial sepsis is a life-threatening situation characterized by multiorgan dysfunction resulting from the body's abnormal response to microbial invasion. Aims: to clarify the potential cardioprotective effect of Trimetazidine against experimentally sepsis-caused endotoxic cardiac injury damage in mice.Material and methods: Material and method: 24 Mice were divided into four groups (n=6): Sham group, CLP group DMSO group, trimetazidine-treated group 50 mg/kg IP, 1hr before CLP, then the animals were sacrificed 24 hr after CLP and tissue sample was taken for measurement of TNF-Α, TNF-Αr1, IL-1β, HO-1, MPO, caspase-11, F2-isoprostane and serum troponin by ELISA and gene expression of AMPK-Nrf2 by qpcr and histopathological study.Results: Results: trimetazidine treated group showed significant changes as compared with clp group regarding TNF-α, TNF-αr1, IL-1β, HO-1, MPO, CASPASE-11, F2-ISOPROSTANE as well as affect tissue mRNA expression of AMPK-Nrf22 genes p<0.05.Conclusions: Conclusion: We evaluate that Trimetazidine has cardio protective effects due to its anti-inflammatory and anti-oxidative action. Also, trimetazidine showed a cardio-protective effect as they affect tissue mRNA expression of AMPK-Nrf2 genes.